No abstract available
Keywords:
ACE2; COVID 19; SARS-CoV2; asthma; inflammation.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Anti-Asthmatic Agents / therapeutic use
-
Asthma / complications*
-
Asthma / drug therapy
-
Asthma / pathology
-
Betacoronavirus / immunology
-
COVID-19
-
Coronavirus Infections / complications*
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / pathology
-
Cytokine Release Syndrome / blood
-
Cytokine Release Syndrome / pathology
-
Cytokines / blood
-
Eosinophils / immunology
-
Gene Expression Regulation / physiology
-
Humans
-
Lung / pathology*
-
Lung / virology
-
Pandemics
-
Peptidyl-Dipeptidase A / metabolism*
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / pathology
-
Pulmonary Disease, Chronic Obstructive / complications*
-
Pulmonary Disease, Chronic Obstructive / pathology
-
SARS-CoV-2
-
Th2 Cells / immunology
Substances
-
Anti-Asthmatic Agents
-
Cytokines
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2